Plasma levels of CXCL7 are significantly reduced in patients with pancreatic cancer, an alteration that occurs at any stage of pancreatic cancer, including the early stages (stages I and II) (Matsubara et al., 2011). Here, PPBP is linked to familial pancreatic carcinoma.